AI assistant
CD PRIVATE EQUITY FUND II — Net Asset Value 2013
Sep 12, 2013
64627_rns_2013-09-12_324bf876-e0b7-486c-b3e0-ab616871e322.pdf
Net Asset Value
Open in viewerOpens in your device viewer
13 September 2013
==> picture [595 x 145] intentionally omitted <==
US Select Private Opportunities Fund II (Fund)
ASX: USG
NTA & Fund Update – 31 August 2013
NTA update
The estimated unaudited net tangible asset value before withholding tax on unpaid distributions at 31 August 2013 was $1.76* per Unit (31 July 2013 was $1.75 per Unit).
Fund update
At 31 August 2013, US Select Private Opportunities Fund II, LP ( LP ) had committed a total of US$40 million (or 58.8% of total capital) in four underlying investments.
Capital call
At 31 August 2013, the LP had made one capital call for consideration of US$10.0 million, representing 14.7% of capital committed. The Fund’s proportionate share of this is approximately US$8.5 million (an 85% share).
Drawdowns
Drawdowns from underlying investments total approximately US$5.9 million, or 8.7% of total funds committed to the LP.
Investment update
During August, US Select Direct Private Equity (US), LP ( US Direct ) completed its first investment, investing alongside DFW Capital Partners ( DFW ) in the parent entity of Sebela International, Ltd and Sebela Pharmaceuticals, Inc. ( Sebela ), a newly-formed specialty pharmaceutical acquisition and licensing platform. The equity investment was made to support the acquisition of a portfolio of branded prescription pharmaceutical products serving the gastroenterology and dermatology markets. For more information see www.sebelapharma.com.
For more information, contact:
Alex MacLachlan 1300 454 801
*Source: Walsh & Company Investments Limited – historical performance is not a guarantee of the future performance of the Fund
The US Select Private Opportunities Fund II has a primary strategy of investing in US smallto-mid-market private investment funds, adopting a fund-of-funds strategy.
==> picture [595 x 69] intentionally omitted <==